Ovarian Ablation for Women With Early-Stage Breast Cancer

To help doctors give their patients the best possible care, the American Society of Clinical Oncology (ASCO) issued an endorsement of a guideline recently developed by Cancer Care Ontario. The guideline evaluates the benefits and risks of ovarian ablation as a treatment option for women with early-stage, invasive breast cancer who have not gone through menopause.

ASCO is always working to broaden the guidelines provided to help doctors care for patients. One approach is to endorse guidelines from other organizations. Guidelines evaluated for endorsement must follow the similar methods ASCO uses to develop guidelines, including a thorough review of the published research.